Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 09:43:23 +0200Tue, 30 Jan 2024 13:00:00 +0100Opinion/decision on a Paediatric investigation plan (PIP): Delstrigo, doravirine,lamivudine,tenofovir disoproxil (fumarate), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0504/2022https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001695-pip01-14-m05Opinion/decision on a Paediatric investigation plan (PIP): Delstrigo, doravirine,lamivudine,tenofovir disoproxil (fumarate), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0504/2022https://www.ema.europa.eu/en/medicines/human/paediatric-investigation-plans/emea-001695-pip01-14-m05Tue, 30 Jan 2024 13:00:00 +0100Human medicine